期刊文献+

环孢素A与他克莫司对大鼠白细胞介素18及白细胞介素10含量的影响

Effect of cyclosporine A and tacrolimus on levels of interleukin-18 and interleukin-10 in rats
原文传递
导出
摘要 目的检测环孢素A(CsA)与他克莫司(FK506)对大鼠血清及脾组织悬液中白细胞介素18(IL-18)及IL-10含量的影响,探讨CsA和FK506抗排斥反应的不同作用机理。方法将60只Wistar大鼠随机分为3组(每组20只):(1)CsA组:以CsA灌胃(30mg·kg-1·d-1);(2)FK506组:以FK506灌胃(0.6mg·kg-1·d-1);(3)对照组:以生理盐水灌胃(3ml·kg-1·d-1)。用全自动生化分析仪检测肝、肾功能,用酶联免疫吸附试验双抗体夹心法测定大鼠外周血及脾组织悬液中IL-18及IL-10的含量。结果FK506组大鼠血清及脾组织悬液中IL-10含量较对照组明显升高,差异有统计学意义(P<0.05),IL-18与对照组比较明显降低,差异有统计学意义(P<0.05);CsA组血清及脾组织悬液中IL-18明显低于对照组(P<0.05),而IL-10与对照组的差异无统计学意义(P>0.05)。结论FK506可使血清及脾组织悬液中IL-10含量升高,这可能是FK506与CsA抗排斥反应机理不同点之一。 Objective To determine the levels of serum and splenic interleukin 18 (IL-18) and IL-10 in rats treated with cyclosporine A (CsA) and tacrolimus (FK506), and to explore the different immunosuppressive mechanism of these two agents. Methods Sixty rats were randomly divided into three groups: CsA group: receiving CsA (30mg·kg^-1·d^-1), gastric irrigation; FK506 group: receiving FK506 (0, 6 mg·kg^-1· d^-1 ), gastric irrigation; control group: receiving normal saline (3 mg·kg^-1·d^-1), gastric irrigation, The parameters of liver and renal function were determined by auto-biochemistry analyzer. The serum and splenic IL-18 and IL-40 levels were determined by using ELISA. Results Serum and splenic IL-10 levels in FK506 group were significantly higher than in CsA group and control group (P〈0. 05). IL-18 levels were decreased significantly in FK506 group as compared with control group (P〈0. 05). In CsA group, serum and spenic IL-18 levels were decreased significantly (P〈0. 05), while IL-10 had no significant change as compared with control group (P2〉 0. 05). Conclusion The increased serum and splenic IL-10 may be one of the causes of taerolimus and CsA with different immunosuppression.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2005年第11期676-678,共3页 Chinese Journal of Organ Transplantation
基金 全军医学科研"十五"规划重点课题(01Z061)
关键词 环孢菌素 免疫抑制剂 白细胞介素类 大鼠 Cyelosporine Immunosuppressive agents Interleukins Rats
  • 相关文献

参考文献13

  • 1Hariharan S, Johnson CP, Bregnatlan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med: 2000, 342:605-612.
  • 2Henry ML. Cyclosporine and tacrolimu(FK506):a comparison of effcacy and safety profiles. Clin Transplant, 1999, 13: 209-220.
  • 3Wasik M, Gorski A, Stepien, et al. Effect of FKS06 versus cyclosporine on human natural and antibody dependent cytotoxicity reaction in vitro. Transplantation, 1991, 51:268-670.
  • 4Migita K, Eguchi K, kawabe Y, et al. FK506 augments activation-induced progmmmed cell death of T lymphocytes in vivo. J Clin Invest, 1995, 96:727-732.
  • 5Laskow DA, Vincenti AF, Neylan J, et al. Phase II FK506 multicenter concentration control study: one year follow-up.Transplant Proc, 1995, 27: 809-811.
  • 6Neuhaus P, Blumhardt G, Bechstein WO, et al. Comparison of FK506 and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. Transplantation, 1995, 59: 31-40.
  • 7Nagano H, Nadeau K, Takeda M, et al. Sequential cellular and molecular kinetics in acutely rejecting renal allograft in rats.Transplantation, 1997, 63: 1101-1108.
  • 8Fung JJ, Abu-Elmagd K, Todo S, et al. Overview of FK506 in transplantation. Clin Transplants 1990, 2:115-121.
  • 9Jiang H, Sakuma S, Fujii y, et al. Tacrolimus versus cyclosporine A: a comparative study on rat renal allograft survival.Transplnt Int, 1999, 12:92-99.
  • 10Onsager DR, CaElver CC, Jahania MS, et al. Effcacy of taerolimus in the treatment of refractory rejection in heart and lung transplant recipients. J Heart Lung Transplant, 1999, 18:448-455.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部